Specific Structural Alteration of the Influenza Haemagglutinin by Amantadine

Overview

Journal EMBO J

Specialties Biotechnology
Molecular Biology

Date 1990 Nov 1

PMID 2209554

Citations 96

Authors

R J Sugrue

G Bahadur

M C Zambon

A R Douglas

A J Hay

Affiliations

Soon will be listed here.

Abstract

Amantadine hydrochloride specifically blocks the release of virus particles from H7 influenza virus infected cells. This appears to be the direct consequence of an amantadine induced change in the haemagglutinin (HA) to its low pH conformation. The effect is indirect and mediated via interaction of the drug with the M2 protein since mutants altered in this component alone are insensitive to amantadine. The timing of drug action, some 15-20 min after synthesis, and its coincidence with proteolytic cleavage indicates that the modifications to HA occur late during transport but prior to insertion into the plasma membrane. Reversal by mM concentrations of amines and 0.1 microM monensin indicates that amantadine action causes a reduction in intravesicular pH which triggers the conformational change in HA. We conclude, therefore, that the function of M2 inhibited by amantadine is involved in counteracting the acidity of vesicular compartments of the exocytic pathway in infected cells and is important in protecting the structural integrity of the acid-sensitive glycoprotein.

Citing Articles

Viroporins Manipulate Cellular Powerhouses and Modulate Innate Immunity.

Cedillo-Barron L, Garcia-Cordero J, Visoso-Carvajal G, Leon-Juarez M Viruses. 2024; 16(3).

PMID: 38543711 PMC: 10974846. DOI: 10.3390/v16030345.

Real-time tracking of drug binding to influenza A M2 reveals a high energy barrier.

Movellan K, Wegstroth M, Overkamp K, Leonov A, Becker S, Andreas L J Struct Biol X. 2023; 8:100090.

PMID: 37363040 PMC: 10285276. DOI: 10.1016/j.yjsbx.2023.100090.

Imidazole: Synthesis, Functionalization and Physicochemical Properties of a Privileged Structure in Medicinal Chemistry.

Tolomeu H, Fraga C Molecules. 2023; 28(2).

PMID: 36677894 PMC: 9865940. DOI: 10.3390/molecules28020838.

Antiviral Approaches against Influenza Virus.

Kumari R, Sharma S, Kumar A, Ende Z, Mishina M, Wang Y Clin Microbiol Rev. 2023; 36(1):e0004022.

PMID: 36645300 PMC: 10035319. DOI: 10.1128/cmr.00040-22.

Functions of Viroporins in the Viral Life Cycle and Their Regulation of Host Cell Responses.

Xia X, Cheng A, Wang M, Ou X, Sun D, Mao S Front Immunol. 2022; 13:890549.

PMID: 35720341 PMC: 9202500. DOI: 10.3389/fimmu.2022.890549.

References

Wilson I, Skehel J, Wiley D . Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature. 1981; 289(5796):366-73. DOI: 10.1038/289366a0. View

Lubeck M, SCHULMAN J, Palese P . Susceptibility of influenza A viruses to amantadine is influenced by the gene coding for M protein. J Virol. 1978; 28(3):710-6. PMC: 525794. DOI: 10.1128/JVI.28.3.710-716.1978. View

Skehel J, Bayley P, Brown E, Martin S, Waterfield M, White J . Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. Proc Natl Acad Sci U S A. 1982; 79(4):968-72. PMC: 345880. DOI: 10.1073/pnas.79.4.968. View

Bukrinskaya A, Vorkunova N, Pushkarskaya N . Uncoating of a rimantadine-resistant variant of influenza virus in the presence of rimantadine. J Gen Virol. 1982; 60(Pt 1):61-6. DOI: 10.1099/0022-1317-60-1-61. View

Warnick J, Maleque M, Bakry N, Eldefrawi A, Albuquerque E . Structure-activity relationships of amantadine. I. Interaction of the N-alkyl analogues with the ionic channels of the nicotinic acetylcholine receptor and electrically excitable membrane. Mol Pharmacol. 1982; 22(1):82-93. View

Graves P, SCHULMAN J, Young J, Palese P . Preparation of influenza virus subviral particles lacking the HA1 subunit of hemagglutinin: unmasking of cross-reactive HA2 determinants. Virology. 1983; 126(1):106-16. DOI: 10.1016/0042-6822(83)90465-8. View

Daniels R, Douglas A, Skehel J, Wiley D . Analyses of the antigenicity of influenza haemagglutinin at the pH optimum for virus-mediated membrane fusion. J Gen Virol. 1983; 64 (Pt 8):1657-62. DOI: 10.1099/0022-1317-64-8-1657. View

Anderson R, Falck J, Goldstein J, Brown M . Visualization of acidic organelles in intact cells by electron microscopy. Proc Natl Acad Sci U S A. 1984; 81(15):4838-42. PMC: 391586. DOI: 10.1073/pnas.81.15.4838. View

Schmidt M . Acylation of viral spike glycoproteins: a feature of enveloped RNA viruses. Virology. 1982; 116(1):327-38. PMC: 7131792. DOI: 10.1016/0042-6822(82)90424-x. View

10.

Ruigrok R, Cremers A, Beyer W . Changes in the morphology of influenza particles induced at low pH. Arch Virol. 1984; 82(3-4):181-94. DOI: 10.1007/BF01311162. View

11.

Daniels R, Downie J, Hay A, Knossow M, Skehel J, Wang M . Fusion mutants of the influenza virus hemagglutinin glycoprotein. Cell. 1985; 40(2):431-9. DOI: 10.1016/0092-8674(85)90157-6. View

12.

Webster R, Kawaoka Y, BEAN W, Beard C, Brugh M . Chemotherapy and vaccination: a possible strategy for the control of highly virulent influenza virus. J Virol. 1985; 55(1):173-6. PMC: 254912. DOI: 10.1128/JVI.55.1.173-176.1985. View

13.

Schwartz A, Strous G, Slot J, Geuze H . Immunoelectron microscopic localization of acidic intracellular compartments in hepatoma cells. EMBO J. 1985; 4(4):899-904. PMC: 554277. DOI: 10.1002/j.1460-2075.1985.tb03716.x. View

14.

Hay A, Wolstenholme A, Skehel J, Smith M . The molecular basis of the specific anti-influenza action of amantadine. EMBO J. 1985; 4(11):3021-4. PMC: 554613. DOI: 10.1002/j.1460-2075.1985.tb04038.x. View

15.

Ruigrok R, WRIGLEY N, Calder L, Cusack S, Wharton S, Brown E . Electron microscopy of the low pH structure of influenza virus haemagglutinin. EMBO J. 1986; 5(1):41-9. PMC: 1166693. DOI: 10.1002/j.1460-2075.1986.tb04175.x. View

16.

Copeland C, Doms R, Bolzau E, Webster R, Helenius A . Assembly of influenza hemagglutinin trimers and its role in intracellular transport. J Cell Biol. 1986; 103(4):1179-91. PMC: 2114319. DOI: 10.1083/jcb.103.4.1179. View

17.

Hay A, Zambon M, Wolstenholme A, Skehel J, Smith M . Molecular basis of resistance of influenza A viruses to amantadine. J Antimicrob Chemother. 1986; 18 Suppl B:19-29. DOI: 10.1093/jac/18.supplement_b.19. View

18.

Boulay F, Doms R, Wilson I, Helenius A . The influenza hemagglutinin precursor as an acid-sensitive probe of the biosynthetic pathway. EMBO J. 1987; 6(9):2643-50. PMC: 553685. DOI: 10.1002/j.1460-2075.1987.tb02555.x. View

19.

Anderson R, Orci L . A view of acidic intracellular compartments. J Cell Biol. 1988; 106(3):539-43. PMC: 2115075. DOI: 10.1083/jcb.106.3.539. View

20.

Belshe R, Smith M, Hall C, Betts R, Hay A . Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection. J Virol. 1988; 62(5):1508-12. PMC: 253174. DOI: 10.1128/JVI.62.5.1508-1512.1988. View